Cross Country Healthcare (CCRN) Misses Q2 EPS by 3c ; Offers Guidance
Tweet
Share
E-mailGet Alerts CCRN Hot Sheet
Price: $13.17 --0%
EPS Growth %: +200.0%
Financial Fact:
Income from operations: 9.33M
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: +200.0%
Financial Fact:
Income from operations: 9.33M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Cross Country Healthcare (NASDAQ: CCRN) reported Q2 EPS of $0.10, $0.03 worse than the analyst estimate of $0.13. Revenue for the quarter came in at $339.77 million versus the consensus estimate of $334.75 million.
GUIDANCE:
Cross Country Healthcare sees Q3 2024 EPS of $0.08-$0.12, versus the consensus of $0.17. Cross Country Healthcare sees Q3 2024 revenue of $305-315 million, versus the consensus of $330.9 million.
For earnings history and earnings-related data on Cross Country Healthcare (CCRN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Starts ICICI Prudential Asset Management (ICICIAMC:IN) at Overweight
- JPMorgan Downgrades KFin Technologies Ltd (KFINTECH:IN) to Neutral
- Shopify To Bar Vapes As U.s. Authorities Crack Down On Illegal Industry - Reuters
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
